Research Article

Related GMR Articles

08/20/2019
Genetic susceptibility; Polymorphism; Protein tyrosine kinase 2; SNP; Type 1 diabetes mellitus

Type 1 diabetes mellitus (T1D) is considered a polygenic disease that is influenced by environmental factors and autoimmune responses to autoantibodies, resulting in metabolic abnormalities. Tyrosine kinase 2 (TYK2) is involved in type I interferon signaling in beta cells, and TYK2 polymorphism rs2304256 has been associated with T1D. We ... more

V. Graciolo; M. Welter; L.P. Campos; B.R. Martins; S.W. Souza; S.N. França; R.R. Réa; G. Picheth; F.G.M. Rego
05/31/2020
Atherosclerosis; eNOS T786C; Nitric oxide; Polymorphism; Stent

Atherosclerosis is a multifactorial chronic-inflammatory disease related to endothelial aggression to the intima layer of medium and large caliber arteries. Hyperlipidemia and atherosclerosis cause eNOS to lose its function, producing superoxide and leading to endothelial dysfunction. The nitric oxide derived from eNOS is anti-atherogenic. Single ... more

A.M. Barbosa; O.S.Dias Neto; K.S.Freitas e Silva; I.B. Lima; U.S. Vilarinho; L.C.A. Gianotti; F.O. de Souza; I.R. da Costa; K.K.V.O. Moura
04/30/2021
Adult-onset; Brazilian population; Childhood-onset; CTLA-4; Polymorphism; Type 1 diabetes

Several studies have described an association between cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and type 1 diabetes mellitus (T1D) in some ethnic populations, and a lack of association in other populations. Differences in the contribution of the genetic background of T1D onset are age dependent. We conducted a case-control study of a T1D ... more

M.M. Sousa; M. Welter; E. Machado; G. Tonet; L.P. Campos; S. Nesi-França; G. Picheth; F.G.M. Rego

Pages